(TRXC) |
0 (0%) 03-29 07:58 |
Open: | |
High: | |
Low: | |
Volume: | 0 |
Market Cap: | 0(M) |
PE Ratio: | 0 |
Exchange: | |
Industry: | |
Sector: |
Technical analysis | ||||
sell | buy |
Resistance 2: | 4.50 |
Resistance 1: | 3.56 |
Pivot price: | 3.30 |
Support 1: | 2.05 |
Support 2: | 1.71 |
52w High: | |
52w Low: |
EPS | -4.803 |
Book Value | 1.050 |
PEG Ratio | 0.00 |
Gross Profit | -0.048 |
Profit Margin (%) | 0.00 |
Operating Margin (%) | -1800.43 |
Return on Assets (ttm) | -32.0 |
Return on Equity (ttm) | -148.6 |
Tue, 26 Mar 2024
Investors Who Bought TransEnterix (NYSEMKT:TRXC) Shares A Year Ago Are Now Down 88% - Yahoo Movies UK
Fri, 15 Mar 2024
TRX to drive economic transformation, catalyst for innovation — TRXC CEO - The Malaysian Reserve
Fri, 14 Jul 2023
The role of thioredoxin proteins in Mycobacterium tuberculosis probed by proteome-wide target profiling - ScienceDirect.com
Tue, 02 Mar 2021
TRXC Stock Has a Lesson That Plenty of Retail Investors Should Learn - InvestorPlace
Sat, 27 Feb 2021
Is TransEnterix a Good Stock to Buy Now? - Nasdaq
Tue, 23 Feb 2021
TransEnterix Announces Name Change to Asensus Surgical and Introduces a New Category of Surgery, Performance ... - Business Wire
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |